Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Kriegsmann

Showing results (151-160 of 178) with videos related to

Pageof 18
Sort By:
Cancers|September 24, 2020
Mass Spectrometry Imaging for Reliable and Fast Classification of Non-Small Cell Lung Cancer SubtypesMark Kriegsmann, Christiane Zgorzelski, Rita Casadonte, et al.
Therapeutic Advances in Medical Oncology|August 19, 2021
Real-world implementation of sequential targeted therapies for EGFR-mutated lung cancerNikolaus Magios, Farastuk Bozorgmehr, Anna-Lena Volckmar, et al.
American Journal of Respiratory and Critical Care Medicine|June 27, 2026
Spatial proteomics profiling reveals oncogene-specific immune niches and prognostic markers in NSCLCRajender Nandigama, Bassem Ben Cheikh, Jochen Wilhelm, et al.
International Journal of Molecular Sciences|July 27, 2022
Specific Targeting of Antiapoptotic Bcl-2 Proteins as a Radiosensitizing Approach in Solid TumorsBenjamin Sobol, Osama Azzam Nieto, Emily Lara Eberlein, et al.
Molecular Systems Biology|August 12, 2022
Drug-microenvironment perturbations reveal resistance mechanisms and prognostic subgroups in CLLPeter-Martin Bruch, Holly Ar Giles, Carolin Kolb, et al.
Gut|March 23, 2019
<i>RSPO2</i> gene rearrangement: a powerful driver of β-catenin activation in liver tumoursThomas Longerich, Volker Endris, Olaf Neumann, et al.
Discover Oncology|October 3, 2023
Preliminary results from the EMoLung clinical study showing early lung cancer detection by the LC scoreKarla Rubio, Jason M Müller, Aditi Mehta, et al.
Science Immunology|November 12, 2021
TRAF6 prevents fatal inflammation by homeostatic suppression of MALT1 proteaseThomas J O'Neill, Thomas Seeholzer, Andreas Gewies, et al.
Cancers|May 28, 2022
Early Assessment of Chemotherapy Response in Advanced Non-Small Cell Lung Cancer with Circulating Tumor DNAStephanie J Yaung, Corinna Woestmann, Christine Ju, et al.
Cancer Immunology, Immunotherapy : CII|June 14, 2021
Deciphering the immunosuppressive tumor microenvironment in ALK- and EGFR-positive lung adenocarcinomaJan Budczies, Martina Kirchner, Klaus Kluck, et al.
Pageof 18

Showing results (151-160 of 178) with videos related to

Sort By:
Pageof 18
Cancers|September 24, 2020
Mass Spectrometry Imaging for Reliable and Fast Classification of Non-Small Cell Lung Cancer SubtypesMark Kriegsmann, Christiane Zgorzelski, Rita Casadonte, et al.
Therapeutic Advances in Medical Oncology|August 19, 2021
Real-world implementation of sequential targeted therapies for EGFR-mutated lung cancerNikolaus Magios, Farastuk Bozorgmehr, Anna-Lena Volckmar, et al.
American Journal of Respiratory and Critical Care Medicine|June 27, 2026
Spatial proteomics profiling reveals oncogene-specific immune niches and prognostic markers in NSCLCRajender Nandigama, Bassem Ben Cheikh, Jochen Wilhelm, et al.
International Journal of Molecular Sciences|July 27, 2022
Specific Targeting of Antiapoptotic Bcl-2 Proteins as a Radiosensitizing Approach in Solid TumorsBenjamin Sobol, Osama Azzam Nieto, Emily Lara Eberlein, et al.
Molecular Systems Biology|August 12, 2022
Drug-microenvironment perturbations reveal resistance mechanisms and prognostic subgroups in CLLPeter-Martin Bruch, Holly Ar Giles, Carolin Kolb, et al.
Gut|March 23, 2019
<i>RSPO2</i> gene rearrangement: a powerful driver of β-catenin activation in liver tumoursThomas Longerich, Volker Endris, Olaf Neumann, et al.
Discover Oncology|October 3, 2023
Preliminary results from the EMoLung clinical study showing early lung cancer detection by the LC scoreKarla Rubio, Jason M Müller, Aditi Mehta, et al.
Science Immunology|November 12, 2021
TRAF6 prevents fatal inflammation by homeostatic suppression of MALT1 proteaseThomas J O'Neill, Thomas Seeholzer, Andreas Gewies, et al.
Cancers|May 28, 2022
Early Assessment of Chemotherapy Response in Advanced Non-Small Cell Lung Cancer with Circulating Tumor DNAStephanie J Yaung, Corinna Woestmann, Christine Ju, et al.
Cancer Immunology, Immunotherapy : CII|June 14, 2021
Deciphering the immunosuppressive tumor microenvironment in ALK- and EGFR-positive lung adenocarcinomaJan Budczies, Martina Kirchner, Klaus Kluck, et al.
Pageof 18